Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20202015Phase 3Completed
A Phase 3 trial of crisugabalin besilate in diabetic polyneuropathy (DPN), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd.. Started Oct 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20202015.